Listed

Mesa Laboratories Inc: Form 10-K for the period ended Mar 31, 2022

Filed with the SEC on May 31, 2022 and accepted by EDGAR at May 31, 2022, 16:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2021-04-01 to 2022-03-31$184.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2021-04-01 to 2022-03-31$75.2mus-gaap:CostOfRevenue
Gross profit12 months2021-04-01 to 2022-03-31$109.1mus-gaap:GrossProfit
Research and development12 months2021-04-01 to 2022-03-31$15.8mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2021-04-01 to 2022-03-31$4.7mus-gaap:OperatingIncomeLoss
Interest expense12 months2021-04-01 to 2022-03-31$3.9mus-gaap:InterestExpense
Income tax12 months2021-04-01 to 2022-03-31$1.7mus-gaap:IncomeTaxExpenseBenefit
Diluted EPS12 months2021-04-01 to 2022-03-31$0.35us-gaap:EarningsPerShareDiluted
Basic EPS12 months2021-04-01 to 2022-03-31$0.36us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2021-04-01 to 2022-03-315,335,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2021-04-01 to 2022-03-31$39.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2021-04-01 to 2022-03-31$4.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2021-04-01 to 2022-03-31$3.3mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2022-03-31$49.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-03-31$124.3mus-gaap:AssetsCurrent
Total assetsAt period end2022-03-31$707.4mus-gaap:Assets
Current liabilitiesAt period end2022-03-31$48.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-03-31$313.6mus-gaap:Liabilities
Shareholders' equityAt period end2022-03-31$393.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-22-013906. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.